Journals in Hematology

11-20 of 36 results in All results

Critical Reviews in Oncology/Hematology

ISSN: 1040-8428
5 Year impact factor: 5.3
Impact factor: 5.5

Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world.The journal considers articles on the following themes:Basic Experimental OncologyCareer Development and Education in OncologyClinical ResearchHematologyImmunotherapyMolecular Pathology, Genomics and omics, and Liquid BiopsyPalliative SupportPediatric OncologyRadiotherapyRegulatory, Ethics, and Health PolicySolid TumorsStatistics, Meta-analysis, and Clinical Trial DesignSurgeryCritical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy (ISLB).All review articles, invited or submitted spontaneously, are subject to peer review before final acceptance. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors.

Current Problems in Cancer

ISSN: 0147-0272
5 Year impact factor: 2.7
Impact factor: 2.5

Current Problems in Cancer seeks to promote and disseminate innovative, transformative, and impactful data on patient-oriented cancer research and clinical care. Specifically, the journal's scope is focused on reporting the results of well-designed cancer studies that influence/alter practice or identify new directions in translational and clinical cancer research. These studies can include novel therapeutic approaches, new strategies for early diagnosis, cancer clinical trials, and supportive care, among others. Pre-clinical studies are discouraged. The journal's format also allows, on occasion, for a multi-faceted overview of a single topic via a curated selection of review articles, while also offering articles that present dynamic material that influences the oncology field.Original case reports featuring prevention, diagnosis and treatment of cancer, supportive care, quality of life and rehabilitation can be submitted to the journal's open access companion title, Current Problems in Cancer: Case Reports.(CPCCR). Any case reports submitted to Current Problems in Cancer (CPC) will be considered for publication in either CPC or CPCCR.

Cytotherapy

ISSN: 1465-3249
5 Year impact factor: 4.3
Impact factor: 3.7

The official journal of the International Society for Cell & Gene Therapy (ISCT®)Cytotherapy, the official journal of the International Society of Cell and Gene Therapy (ISCT), publishes novel and innovative results from high quality scientific and clinical studies in the fields of cell and gene therapy. In addition to Short Reports and Full-Length Articles, the journal also accepts Editorials on emerging trends and potential controversies in the field, and Review articles summarizing important areas of cell and gene therapy research that are topical and/or challenge existing paradigms in the field.Cytotherapy considers manuscripts exploring the following topics:Development and/or characterization of novel gene therapies and cell and/or EV-based therapeuticsDesign of novel therapeutic approaches employing cell/EV/gene products.Mode of action of cell/EV/gene therapies in relevant cell-based and pre-clinical models.Identification of novel biomarkers that predict the potency of cell/EV/gene therapies and/or stratify patients based on response rates.Role of stem/stromal cells and/or EVs in disease pathophysiology.Early and late phase clinical studies evaluating the safety and efficacy of cell/EV/gene therapies.Important advances in cell/EV/gene-based product manufacturing and validationGlobal/regional regulatory practices that impact the authorized use and/or regulatory approval of cell/EV and gene therapies.Cytotherapy does not publish manuscripts on the following topics:Case studies unless they are of unusual significance to the field.Basic/translational studies exploring the role of lncRNAs, circRNAs, and miRNAs in disease pathophysiologyStudies describing signaling pathways implicated in cancer

European Journal of Cancer

ISSN: 0959-8049
5 Year impact factor: 7.7
Impact factor: 7.6

Official Journal of EORTC and EUSOMAThe European Journal of Cancer (EJC) integrates preclinical, digital, translational, and clinical research in cancer, from epidemiology, carcinogenesis and biology through to innovations in cancer treatment and patient care. The journal publishes original research, reviews, previews, editorial comments and correspondence.The EJC is the official journal of the European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Breast Cancer Specialists (EUSOMA).

European Journal of Oncology Nursing

ISSN: 1462-3889
5 Year impact factor: 3
Impact factor: 2.7

The European Journal of Oncology Nursing is an international journal which publishes research of direct relevance to patient care, nurse education, management and policy development. EJON is proud to be the official journal of the European Oncology Nursing Society.The journal publishes the following types of papers: • Original research articles • Review articlesBenefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

European Journal of Surgical Oncology

ISSN: 0748-7983
5 Year impact factor: 3.6
Impact factor: 3.5

Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer SurgeryThe EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.The Editors welcome submissions on clinical research and all other aspects of surgical oncology which advance the care of patients with cancer, including surgical quality control, epidemiology, preventative aspects of surgical oncology, as well as translational research relevant to surgical oncology practice.We offer many author benefits including Your Paper, Your Way (YPYW). YPYW is an easier submission process, focusing on the quality of the science in the initial stages of submission and only requiring elements needed for eventual production at the revision stage. Please refer to the Guide for Authors for further information.

Experimental Hematology

ISSN: 0301-472X
5 Year impact factor: 2.6
Impact factor: 2.5

Journal for Hematology, Stem Cell Biology and TransplantationOfficial publication of the ISEH - International Society for Experimental HematologyExperimental Hematology publishes new findings, methodologies, reviews and perspectives in all areas of hematology and immune cell formation. The goal is to report new insights into how normal blood cells are produced, how their production is normally regulated, mechanisms that contribute to hematological diseases and new approaches to their treatment.The journal publishes topics including:Relevant developmental and aging processesStem cell biologyAnalyses of intrinsic and extrinsic regulatory mechanismsIn vitro behavior of primary cellsClonal trackingMolecular and omics analysesMetabolismEpigeneticsBioengineering approachesStudies in model organismsNovel clinical observationsTransplantation biology and new therapeutic avenuesExperimental Hematology publishes two types of articles: Reviews and Perspectives and original findings sub-classified either as Brief Communications of significant singular results and Research Articles presenting the results of more developed studies.Experimental Hematology publishes Special Issues dedicated to important topics in the field. To view our Special Issues and article collections, click here.

Hematology/Oncology Clinics of North America

ISSN: 0889-8588
5 Year impact factor: 3.2
Impact factor: 2.5

Hematology/Oncology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers—bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more. Hematology/Oncology Clinics of North America is published six times each year, in February, April, June, August, October, and December.

Hematology/Oncology Clinics of North America

International Journal of Radiation Oncology, Biology, Physics

ISSN: 0360-3016
5 Year impact factor: 6.1
Impact factor: 6.4

An official journal of the American Society for Radiation OncologyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.The Red Journal's related publications are Practical Radiation Oncology and Advances in Radiation Oncology. Learn more about which types of papers these journals typically accept.Disclaimer No responsibility is assumed by the Publisher or the American Society for Radiation Oncology for any injury and/or damage to persons or property as a result of any actual or alleged libelous statements, infringement of intellectual property or privacy rights, products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.The views expressed in The Red Journal (the "Journal") are those of the individual authors and are not necessarily those of the American Society for Radiation Oncology (ASTRO) or the Publisher. The information contained in the Journal is not medical advice and is not intended to replace the judgment of a practitioner with respect to particular patients, procedures, or practice. No responsibility is assumed by the Publisher nor by the Society for any injury and/or damage to persons or property as a result of (i) any actual or alleged libelous statements or infringement of intellectual property or privacy rights, (ii) product liability or negligence; (iii) an author's statements or other materials; or (iv) the use or operation of any ideas, instructions, procedures, products, or methods contained in the Journal. Due to rapid advances in the medical sciences, independent verification of diagnoses and drug dosages should always be made. In any jurisdiction that does not permit such a disclaimer of liability, the liability of ASTRO and the Publisher shall be limited to the greatest extent allowed by applicable law.Publication of an advertisement in the Journal does not constitute on the part of the Publisher or the Society a guarantee or endorsement of the quality or value of the advertised products or services described therein or of any of the representations or the claims made by the advertisers with respect to such products or services.

Journal of Thrombosis and Haemostasis

ISSN: 1538-7836
5 Year impact factor: 6.6
Impact factor: 5.5

The Journal of Thrombosis and Haemostasis (JTH) is the official journal of the International Society on Thrombosis and Haemostasis. The mission of JTH is to advance science related to the important medical problems of thrombosis, bleeding disorders and vascular biology through the diffusion and exchange of information and ideas within the international research community. The Journal publishes high quality, original research reports, state of the art reviews, brief reports, case reports, invited commentaries on publications in the Journal, forum articles, correspondence and announcements. Editors invite both fundamental and clinical contributions.These include basic manuscripts on blood coagulation and fibrinolysis, proteins and reactions, blood platelets, and the interaction of all these components with other biological systems such as, but not limited to, the vessel wall, blood cells, and invading organisms. Clinical manuscripts can cover a wide variety of topics including venous thrombosis and arterial disease, plus hemophilia and other bleeding disorders, as well as platelet diseases. The subject area of clinical manuscripts can range from etiology to diagnostics, prognosis, prevention, and treatment.

Life sciences

Physical sciences & Engineering

Social sciences & Humanities

Health